|
Session 116
Poster Abstracts
Drug Resistance: Special Populations and Outcomes
Wednesday, 1 - 4 pm
Poster Hall |
658
 |
High Prevalence of Primary Lamivudine and Nelfinavir Resistance in HIV-1-infected Pregnant Women in the United Stated, 1998-2003
Roger Paredes*1,2, Roger Paredes*1,2, I Cheng3, D Kuritzkes1, R Tuomala1, and Women and Infants Study Group (WITS)
1Brigham and Women's Hosp, Harvard Med Sch, Boston, MA, US; 2Fndn irsiCaixa, Univ Autonoma de Barcelona, Catalonia, Spain; and 3Clinical Trials & Surveys Corp, Baltimore, MD, US |
659
|
Resistance Mutations Predict Mortality in HIV Patients with Triple-class Antiretroviral Drug Failure
Nicolai Lohse*1, L Jørgensen2, N Obel3, J Gerstoft4, and The Danish HIV Cohort Study
1Aarhus Univ Hosp, Denmark; 2Statens Serum Inst, Copenhagen, Denmark; 3Odense Univ Hosp, Denmark; and 4Copenhagen Univ Hosp, Rigshospitalet, Denmark |
660
|
Improved Survival Associated with Use of HIV Susceptibility Testing among HAART-experienced and Therapy-naïve Patients in the HIV Outpatient Study
Frank Palella, Jr.*1, C Armon2, J Chmiel1, K Buchacz3, R Novack4, K Wood2, A Moorman3, J Brooks3, and the HIV Outpatient Study (HOPS) Investigators
1Feinberg Sch of Med, Northwestern Univ, Chicago, IL, US; 2Cerner Corp, Vienna, VA, US; 3CDC, Atlanta, GA, US; and 4Univ of Illinois at Chicago, Coll of Med, US |
|
